Pharma and Biotech Patent Litigation Conference

C5
March 14-15, 2016

John Murnane spoke on “Biosimilar and Biologic Status in the United States: Application of the BPCIA after Amgen v. Sandoz” at the C5 Pharma and Biotech Patent Litigation conference in Amsterdam on March 14-15.  Rachael Million-Perez prepared the slides used in the presentation.